1155372-79-4

Basic information

• Product Name: 4-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-(4-(N,N-dimethylamino)benzyl)oxazole-5-carboxamide
• Synonyms: 4-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-(4-(N,N-dimethylamino)benzyl)oxazole-5-carboxamide
• CAS NO: 1155372-79-4
• Molecular Weight: 575.707
• Mol File: 1155372-79-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-(4-(N,N-dimethylamino)benzyl)oxazole-5-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-(4-(N,N-dimethylamino)benzyl)oxazole-5-carboxamide(1155372-79-4)
• EPA Substance Registry System: 4-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-(4-(N,N-dimethylamino)benzyl)oxazole-5-carboxamide(1155372-79-4)

Safety Data

• Hazardous Substances Data: 1155372-79-4(Hazardous Substances Data)

Upstream product

• 1155372-75-0 4-(5-isopropyl-2,4-dimethoxyphenyl)oxazole-5-carboxylic acid 
• 10003-74-4 4-(dimethylamino)benzylamine dihydrochloride salt 

Relevant articles and documents

4-SUBSTITUTED-6-ISOPROPYL-BENZENE-1,3-DIOL COMPOUNDS AND THEIR USE

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain 4-substituted-6-isopropyl-benzene 1,3-diol compounds (referred to herein as IBD compounds), which, inter alia, inhibit heat shock protein 90 (HSP90) function. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HSP90 function, and in the treatment of diseases and conditions that are mediated by HSP90, that are ameliorated by the inhibition of HSP90 function, etc., including proliferative conditions such as cancer, etc.